Vise Technologies’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,098
Closed -$500K 1923
2026
Q1
$500K Hold
8,098
0.01% 868
2025
Q4
$500K Buy
8,098
+3,451
+74% +$211K 0.01% 873
2025
Q3
$290K Sell
4,647
-308
-6% -$21.4K 0.01% 903
2025
Q2
$396K Buy
+4,955
New +$414K 0.02% 730
2024
Q4
$319K Buy
+4,085
New +$317K 0.03% 567
2024
Q2
Sell
-2,962
Closed -$215K 438
2024
Q1
$215K Sell
2,962
-1,229
-29% -$82.2K 0.04% 352
2023
Q4
$257K Sell
4,191
-840
-17% -$49.9K 0.06% 297
2023
Q3
$288K Sell
5,031
-102
-2% -$6.17K 0.07% 248
2023
Q2
$305K Sell
5,133
-675
-12% -$40.4K 0.07% 245
2023
Q1
$364K Sell
5,808
-75
-1% -$4.68K 0.1% 214
2022
Q4
$368K Buy
5,883
+497
+9% +$28.5K 0.12% 195
2022
Q3
$268K Buy
5,386
+301
+6% +$16.7K 0.1% 230
2022
Q2
$299K Buy
+5,085
New +$280K 0.12% 197

Other funds holding PBH

Vise Technologies's PBH Position: Q2 2026 in Review

Vise Technologies sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 8,098 shares — an estimated $500K sold.

Vise Technologies first reported a position in PBH in Q2 2022 and held it in 13 quarters. The position peaked at $500K in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Vise Technologies reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Vise Technologies sold 8,098 Prestige Consumer Healthcare shares in Q2 2026, an estimated $500K.
  • Vise Technologies first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 13 quarters.
  • Vise Technologies's Prestige Consumer Healthcare position peaked at $500K in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.